Resmed
Resmed
ResMed is due to report 4Q23E EPS Friday.

Resmed
ResMed is due to report 4Q23E EPS Friday.

Resmed
Resmed
ResMed is under Algo Engine buy conditions.

Resmed – Add Watchlist
ResMed is approaching a price range where we’re likely to see a new Algo Engine buy condition.

Resmed – Support Zone
ResMed is under Algo Engine buy conditions and we see buying support building within the $30 – $33 price range.

Resmed – Algo Buy
ResMed is under Algo Engine buy conditions and we see buying support building.

Resmed – Support Level
ResMed is under Algo Engine buy conditions and is now up 84% since being added to our model in October 2018.
RMD delivered a solid earnings result and upgrades to earnings are partially offset by the stronger AUD.
RMD is looking to resume share buybacks in 2H21.
We see buying support at $26 and suggest investors look to accumulate the stock.

Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.